Survey of water proton longitudinal relaxation in liver in vivo by Waterton, John Charles
Vol.:(0123456789) 
Magnetic Resonance Materials in Physics, Biology and Medicine (2021) 34:779–789 
https://doi.org/10.1007/s10334-021-00928-x
REVIEW
Survey of water proton longitudinal relaxation in liver in vivo
John Charles Waterton1,2 
Received: 20 January 2021 / Revised: 5 April 2021 / Accepted: 27 April 2021 / Published online: 12 May 2021 
© The Author(s) 2021
Abstract
Objective To determine the variability, and preferred values, for normal liver longitudinal water proton relaxation rate R1 
in the published literature.
Methods Values of mean R1 and between-subject variance were obtained from literature searching. Weighted means were 
fitted to a heuristic and to a model.
Results After exclusions, 116 publications (143 studies) remained, representing apparently normal liver in 3392 humans, 99 
mice and 249 rats. Seventeen field strengths were included between 0.04 T and 9.4 T. Older studies tended to report higher 
between-subject coefficients of variation (CoV), but for studies published since 1992, the median between-subject CoV was 
7.4%, and in half of those studies, measured R1 deviated from model by 8.0% or less.
Discussion The within-study between-subject CoV incorporates repeatability error and true between-subject variation. 
Between-study variation also incorporates between-population variation, together with bias from interactions between 
methodology and physiology. While quantitative relaxometry ultimately requires validation with phantoms and analysis 
of propagation of errors, this survey allows investigators to compare their own R1 and variability values with the range of 
existing literature.
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Introduction
The liver longitudinal water proton relaxation rate R1 is 
important for several reasons. Native R1 is a biomarker 
of liver pathology [1, 2]. Also, other liver biomarkers are 
secondarily derived from R1 measurements: for example, 
increase in R1 post-gadoxetate is a biomarker of hepatocyte 
function [3, 4]; extracellular volume is derived by compar-
ing R1 pre and post contrast [5]; and baseline R1 is required 
for rate constants in dynamic contrast-enhanced MR [6], for 
tissue oxygen tension in oxygen-enhanced MR [7], and for 
relaxivity measurements in contrast agent research[8].
Measurements of R1 in individual livers or liver regions 
suffer from both systematic errors and random errors [9]. 
Systematic errors (bias) arise because measurements are 
imperfectly performed. Other systematic deviations occur 
because different methods, even when perfectly performed, 
yield R1 values with different dependences on liver compo-
sition and physiology. Random (repeatability) errors arise 
from physiologic and instrument noise, and can be high 
particularly when regions-of-interest are small. In addi-
tion, even in the absence of bias and noise, there are, in 
each study, genuine between-subject differences in R1 due 
to between-subject variation in physiology or subclinical 
pathology.
To mitigate the effects of random error in establishing 
a “normal” or “baseline” liver R1, investigators sometimes 
employ a "compromise" R1, averaged from all subjects in 
their study. This likely reduces the "noise" variance, but 
introduces other errors by ignoring true between-subject 
variation. Other investigators may obtain R1 from literature 
reports, although this will introduce additional bias if dif-
ferent measurement methods had been used, or different 
populations had been studied.
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The aim of this study was to survey values, and variabili-
ties, of normal liver R1 from the published literature. This 
would give investigators an indication of whether the liver 
R1 or T1 values and variabilities they measure are broadly 
consistent with, or discordant from, the prior literature.
Methods
Literature searching
Literature was searched manually using "Ovid Medline" 
(www. ovid. com) for “magnetic resonance imaging” AND 
“liver” AND “relaxation”. Additional literature reports were 
retrieved from citations, supplemented by a more intensive 
search for data with  B0 = 4.7 T, 7 T, 9.4 T, 11.7 T, 14.1 T 
or 21.1 T (see supplementary material 1 for further details). 
Liberal inclusion criteria were employed: any report, in 
any language, which claimed to measure liver R1 or T1 was 
included, irrespective of methodology or study design. Stud-
ies where  B0 was unclear, or where liver R1 or T1 was meas-
ured but not reported, were necessarily excluded. Studies 
using Look-Locker methods were included if they reported 
T1 or R1, but excluded if they reported an apparent T1* only. 
Human and rodent subjects were included if they were nor-
mal controls of any age, if the study reported normal parts 
of livers with focal disease, or if they were patients in whom 
no liver abnormality had been found. Studies of definitely 
pathological liver, suspected duplicates, and ex vivo studies 
were excluded.
Analysis
The mean and variance of R1 across all subjects in each 
study was estimated from the publications, with the coeffi-
cient of variation given by CoV =
√
variance∕mean . Where 
measurements were made on the same subjects using the 
same method (repeatability), the weighted mean ± SD was 
used, however where measurements were made on the 
same subjects using different method (e.g., different field 
strengths) the measurements were treated as if from two dif-
ferent studies. Any R1 measurement method was allowed, as 
long as T1 (s) or R1  (s−1) was reported. Where T1 ± SD was 
reported, a point estimate of R1 was estimated as T1−1 and 
the between-subject variance in R1 was estimated (see sup-
plementary material 2) as:
In a few cases, the between-subject variance in R1 was 
estimated from a bar or scatterplot depicted in the publica-
tion, or from the range rule [10]. To aggregate the data, 
individual studies were weighted by the inverse of their 
between-subject variance in R1. Studies with N = 1, or 
where a variance could not be extracted, were included in 
Figs. 1 and 2, but their R1 was assigned zero weight in the 
fits. In addition, a method to account for the well-known 
 B0-dependence of liver R1 [11–15] was needed. Two meth-
ods of representing this  B0 dependence were used: a heuris-
tic log–log relationship, and a biophysical power-law model 
developed by Diakova et al. [12]. R1 was fitted to  B0 using 
the weighted non-linear least squares function nls() in R[16] 
(see supplementary material 3). The fitted parameters in the 
heuristic were M and C:
The fitted parameters in the model were A and B:
where R1,∞ is the high-frequency asymptote, i.e., the extreme 
narrowing condition, set here to 0.213  s−1 at 310 K[17]; 
D
 
is the translational correlation time from Diakova et al. [12] 
adjusted for temperature to 1.43 ×  10–11 s; k = −0.6 also 
from Diakova et al. [12]; and  = 2 × 42.58 × 106 × B0 
 s−1. In the summaries, lower (LQ) and upper (UQ) quartiles, 
and medians, are reported. For exploratory fits using other 
weightings, see Supplementary Material 4.
Results
Approximately 500 publication abstracts were read, from 
which around 270 publications were selected and reviewed. 
After exclusions, 116 publications remained, with publi-
cation dates between 1981 and 2020. Some publications 
reported multiple studies, or multiple groups within a single 
study, so that 143 studies were available to contribute to this 
analysis. These represented 3392 humans [1–4, 7, 11, 14, 15, 
18–94], 99 mice [95–105] and 249 rats [5, 33, 105–126]. 
The number of subjects per study varied between 1 and 1037 
(median 12). A very wide variety of T1 measuring methods 
was used. Frequently used approaches (see supplementary 
material 5) were inversion-recovery (18% of studies), satu-












































Fig. 1  Log–log dependence of longitudinal relaxation rate on field 
strength. Blue: human; Red: rat; Green: mouse. Each symbol rep-
resents one study. Size of circle reflects number of subjects (some 
smaller symbols are occluded by larger symbols). Dashed black 
line: fit to Eq. 2. Solid black line: fit to Eq. 3 with R1,∞ = 0.213  s−1. 
The dotted line illustrates, for the benefit of investigators work-
ing at > 10 T, fits to Eq. 3 where R1,∞ was fixed at higher values of 
0.4  s−1, 0.6  s−1, and 0.8  s−1, intermediate between 0.213  s−1 and the 
0.9–1.0  s−1 value observed at 9.4 T in Table 1
◂
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compare signal arising respectively when inversion time, 
repetition time, or flip angle are incremented. The median 
number of increments was 3 (range 2–20). Various read-outs 
were employed including spin-echo, gradient-echo, echo-
planar or localized spectroscopy. Other studies employed 
variants of Look-Locker (24%) or MR fingerprinting (1%). 
Some studies reported that they suppressed fat, and/or cor-
rected for iron-induced T1-shortening; some reported motion 
suppression, registration, triggering, gating or breath-hold; 
some reported  B1 correction or phantom-based validation. 
Some studies analysed quite small regions of interest often 
avoiding blood vessels and bile ducts; others included most 
or all of the liver. Seventeen field strengths were included 
between 0.04 T and 9.4 T. No values were found in reports 
using  B0 > 9.4 T: one report of T∗1 = 1.0 ± 0.1 s at 14.1 T 
was excluded[127]. Figures 1 and 2 show plots of R1 against 
 B0, in which R1 shows the expected decrease with increas-
ing field: Table 1 gives values for the most important field 
strengths. The fit to Eq.  2 gave M = −0.3611 ± 0.0115 
and C = 0.2956 ± 0.0073 .  The f it  to Eq.  3 gave 
A = (8.663 ± 0.681) × 104 and B = (1.294 ± 0.082) × 109 . 
An exploratory attempt at a three-parameter fit to Eq. 3 (i.e., 
to A, B, and R1,∞ ) failed to provide evidence for R1,∞ > 0 
(supplementary material 4). When data were subgouped by 
species or by method, no evidence was found that the sub-
goup R1 values deviated systematically from Eq. 3 (supple-
mentary material 6). Across all studies, the median between-
subject CoV was 9.1% (LQ 5.9%, UQ 16.5%, rms 17.0%). 
There was, however, a tendency for early studies to report 
high between-subject CoV (Fig. 3 and supplementary mate-
rial 7): no study published after 1992 had CoV ≥ 20%, and 
for post-1992 studies the median between-subject CoV was 
7.4% (LQ 5.6%, UQ 11.0%, rms 9.6%). In half those studies, 
the measured R1 deviated from Eq. 3 by 8.0% or less (LQ 
2.8%, UQ 16.6%).
At each field strength, there was considerable variation 
in R1 between studies: the between-study CoV was 16% for 
post-1992 studies. Six publications[2, 37, 98, 119, 128, 129] 
also reported liver R1 repeatability (same subject, different 
scan, same measurement conditions): the rms CoV was 
1.9%. These CoVs allowed a crude estimate (supplemen-
tary material 8) of the relative size of the three main vari-
ance components: repeatability variance contributed ~ 1%; 
within-study-between-subject variance contributed ~ 25%; 
and between-study variance contributed ~ 74%.
Fig. 2  Dependence of longitudinal relaxation rate on field strength. 
Each symbol represents one study. Dashed black line: Eq.  2. Solid 
black line: Eq. 3. Dotted line: R1,∞ = 0.213s−1
Table 1  Preferred R1 values 
 (s−1) for five commonly used 
field strengths, derived from the 
data and from the fits
Five different methods of generating a preferred R1 are illustrated: the model fit (in bold) makes greatest 
use of the available information
B0 (T) Mean over 
studies (N stud-
ies)





Fitted to heuristic Eq. 2 





9.4 0.90 (4) 1.01(4) 0.89(38) 0.88 0.92
7 1.02 (9) 1.02(9) 1.00(56) 0.98 1.02
4.7 1.12 (5) 1.22 (5) 1.05(34) 1.13 1.15
3 1.34 (36) 1.42(36) 1.29(989) 1.33 1.33
1.5 1.66 (37) 1.47(37) 1.55(1700) 1.71 1.66
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Discussion
In liver, as in pure water, both intramolecular and inter-
molecular water 1H-1H dipolar relaxation contribute to R1. 
Specific additional contributors to water 1H R1 in liver arise 
from 1H-1H dipolar relaxation between water and other mol-
ecules, and 1H-electron dipolar relaxation between water and 
various iron- or copper-containing substances or dioxygen. 
These 1H-containing and unpaired-electron-containing sub-
stances differ in concentration between subjects. The liver 
1H resonance arises mostly from tissue water in hepatocytes. 
Other contributions come from water in other intracellu-
lar compartments (e.g., Kupffer cells, erythrocytes), and 
in extracellular compartments (e.g., bile, plasma, space of 
Disse). Signal from triglyceride and inflowing blood may 
contribute, depending on the sequence used. Macromol-
ecules contribute to the signal, notably collagen and gly-
cogen which have different concentrations in different sub-
jects. These factors likely account for some of the variation 
between subjects and between studies.
Fits from the heuristic and from the model were very 
similar. The main difference is that the heuristic forces R1 to 
zero at infinite field, while the model forces R1 to asymptote 
in the extreme narrowing condition. This difference might 
become important at fields above 7 T (Fig. 1). In this study, 
following Diakova et al.[12], the asymptote R1,∞ was fixed 
at 1/4.7  s−1, equal to the R1 of pure deoxygenated water 
at 310 K at high field [17]: a slightly higher value would 
be more appropriate if R1 values from liver water and pure 
water do not converge as illustrated in Fig. 1.
The relative magnitude of the major variance components 
was estimated. This is very crude, and given the heterogene-
ity and variable quality of the raw data, should be considered 
a rough guide only. The within-study between-subject CoV 
reflects not only repeatability error (~ 1% of the variance), 
but also the expected between-subject variation (~ 25% of the 
variance). Between-study variation (~ 74% of the variance) 
also includes between-population variation, together with bias 
from interactions between each study’s measurement method 
and its livers’ variation in flow, motion, fat, oedema, colla-
gen, glycogen and iron. R1 may also change after a meal [89], 
during the menstrual cycle [25] or with drug treatment [25].
The literature survey was not fully PRISMA-compliant 
[130] and is unlikely to be complete. Studies explicitly of 
liver R1 or T1 as a biomarker are readily retrieved, because 
Fig. 3  Within-study between-subject coefficient of variation as a function of year of publication
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appropriate keywords are generally used in the title and 
abstract. However, for studies where liver R1 or T1 measure-
ment is incidental to another objective, for example extra-
cellular volume, relaxivity, or dynamic contrast-enhanced 
studies, suitable keywords may not have been included.
There is no single “correct” value for any liver’s 1H R1. 
R1 may vary spatially across the liver [60, 119]. Water 1H R1 
is multiexponential, particularly with sequences where mac-
romolecule-associated fast-relaxing water contributes to the 
measurement. Other substances in the liver may also contrib-
ute to the 1H signal, such as glycogen [87] or triglyceride [76, 
131]. Inflowing blood [110, 132], physiologic motion [71], 
magnetization transfer, and iron affect the measured R1 in 
ways which depend both on the sequence and on the analysis 
employed. There may be systematic differences in R1 between 
fat-suppressed vs. non-fat-suppressed acquisitions; 2D acqui-
sitions more vulnerable to inflow effects than 3D; breathhold 
or gated vs. free-breathing; and so on. Some investigators 
advocate the use of a “corrected” T1 to avoid bias caused by 
the relaxivity of iron-containing substances [65]. Because of 
these biases in the literature, studies which deviate from these 
survey data should not immediately be considered “incorrect”, 
but if large deviations are observed, then an explanation on 
methodological or physiological grounds should be sought.
There are some other limitations. While some publica-
tions reported carefully designed and conducted biomarker 
validation studies, in other publications, the precise value 
of T1 was only of incidental interest and possibly acquired 
with less care. However, in this survey, the study design 
and objectives were not incorporated into the weightings. 
Most studies did not report validation of their liver R1 by 
means of a phantom, so accuracy is unknown. It was difficult 
to explore the effect of methodology on R1, because some 
studies used methodology which was poorly described or 
did not appear robust, and because of correlation between 
field strength and methodology (old studies used old meth-
odology and lower fields). Likewise, there was correlation 
between field strength and species (humans at low-medium 
fields, rats at medium–high fields and mice at high fields), 
so it was difficult to compare between species.
Conclusion
Quantitative relaxometry requires validation with phantoms 
and analysis of propagation of errors. However, it is also 
good scientific practice to compare one’s own findings with 
prior literature. An investigator who finds their average liver 
R1 in normal liver to be within 8% of the fit to Eq. 3, with 
between-subject CoV < 8%, can conclude that their measure-
ments are in agreement with the majority of the literature: 
for measurements far outside these limits, a physiological or 
methodological explanation should be sought.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s10334- 021- 00928-x.
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